Cynomolgus monkey and transgenic Tg2576 mouse (murine surrogate and aducanumab); rat for reproductive studies
“The toxicology of aducanumab was adequately assessed in general toxicity studies in monkey and Tg2576 mouse.”
✓ VerifiedFDA pharmacology/toxicology review, p. 7Source ↗
Why that species
Target is aggregated Aβ, absent in rodents and non-aged monkeys, so neither rat nor monkey is fully relevant
“Neither rat nor monkey is a particularly relevant species for general toxicity because of the lack of aggregated amyloid in rodent or non-aged monkey.”
✓ VerifiedFDA pharmacology/toxicology review, p. 2Source ↗
Surrogate molecule
Yes: murine chimeric analog ch12F6A, used for 13-week and 6-month toxicity studies in aged Tg2576 mice
“In Tg2576 mouse, ch12F6A was administered for 13 weeks (0, 10, 70, or 500 mg/kg) or 6 months (0, 10, 40, or 250 mg/kg) weekly by intravenous injection; in each study, a separate group received aducanumab (500 or 250 mg/kg, respectively) according to the same regimen.”
✓ VerifiedFDA pharmacology/toxicology review, p. 3Source ↗